Updated Monday through Friday
- Drug Firm Annual Registration Status
- Drug Firm Annual Registration Status Download File
- National Drug Code Directory
- NDC Unfinished Drugs Excluded Database File
- NDC Database Excluded Packages and Products
- Wholesale Distributor and Third-Party Logistics Providers Reporting
July 29, 2020
- A Pharmaceutical Quality Webinar for Global Stakeholders
- FDA Drug Safety Podcast: FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder
- Guidance for Industry:
- Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products-Content and Format
- Expiration Dating of Unit-Dose Repackaged Solid Oral Dosage Form Drug Products
- Pathological Complete Response in Neoadjuvant Treatment of High-Risk Early-Stage Breast Cancer: Use as an Endpoint to Support Accelerated Approval
- Activities Report of the Generic Drugs Program | GDUFA II Quarterly Performance (updated)
.png)
No hay comentarios:
Publicar un comentario